Hello Harvest One Investors,

Welcome to the June 2019 edition of our newsletter. The end of June represents the end of our 2019 fiscal year. Several key objectives were executed within this past year and investors are starting to see significant milestones from Harvest One and our subsidiaries.

This week, we announced the closing of the Delivra acquisition and we are excited to welcome Dr. Joseph **riele and his team to the Harvest One family. Not only are we excited about the brands, but with the addition of Dr. Joe, we have added a formulation expert to our team. Delivra’s brand, LivRelief™, is Canada’s leading nerve pain relief topical and will be added to our existing portfolio. This also ensures that Harvest One will be amongst the first movers on cannabinoid-infused topicals in Canada later this year and globally, where regulations allow.

Early this month, Satipharm achieved a major milestone as it announced its entrance into brick & mortar stores through a supply agreement with Holland & Barrett, Europe’s largest retailer of nutritional supplements and wellness products. Satipharm’s 10mg CBD Gelpell® capsules are now available in 1300 stores throughout Ireland and the UK. This signals the first of many supply agreements with retailers as Satipharm works to expand its distribution network in Europe.

In June, Health Canada released new regulations for Cannabis 2.0, providing a framework for the official legalization of derivative products. These new regulations support Harvest One’s strategy as we work towards the infusion of our LivRelief™ and Dream Water brands as well as other select products under development such as vapes and edibles.

It is important to note that construction remains in progress at both our Duncan and Lucky Lake facilities, as we continue to scale up capacity to support our retail supply agreements and future product development.

Considering recent market conditions within the cannabis sector, year to date, our stock price has performed favourably in comparison to our peers. We remain focused on the key strategic initiatives of our business and will continue to execute on our strategy to ensure the long-term growth and success of the company.

Thank you for your continued support on our journey.

Grant Froese
CEO